Vertex Pharmaceuticals (VRTX)
(Real Time Quote from BATS)
$467.11 USD
+11.77 (2.59%)
Updated Jun 3, 2024 11:06 AM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Brokerage Reports
Vertex Pharmaceuticals Incorporated [VRTX]
Reports for Purchase
Showing records 321 - 326 ( 326 total )
Company: Vertex Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Vertex Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: Vertex Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.
Company: Vertex Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Uneventful Q4:09 Financials; Telaprevir-Boceprevir Phase III Data Showdown Next
Provider: WEDBUSH SECURITIES INC.
Company: Vertex Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet.
Provider: MERRIMAN CURHAN FORD & CO.
Company: Vertex Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Downgrading to Relative UNDERPERFORM on Valuation; Maintaining $45 PT.
Provider: WEDBUSH SECURITIES INC.